Lv1
8 积分 2022-10-22 加入
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
4天前
已完结
Allogeneic stem cell transplantation achieves long-term remissions in mantle cell lymphoma, including in TP53 -mutated disease
4天前
已完结
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation
7天前
已完结
Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG
2个月前
已完结
Chronic Myeloid Leukemia
2个月前
已完结
Blinatumomab and Ponatinib for Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updated Results and Predictors of Relapse
2个月前
已关闭
How I treat acute lymphoblastic leukemia in the era of immunotherapy while revisiting the myth of second remission
2个月前
已完结
Haemophagocytic lymphohistiocytosis and Epstein–Barr virus: a complex relationship with diverse origins, expression and outcomes
2个月前
已完结
Transplantation in Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Yes or No?
2个月前
已完结
Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL
2个月前
已完结
皖公网安备34019202002308
